• 1
    Burdick RA, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOOPS. Kidney Int 2003; 63: 22229.
  • 2
    Petrosillo N, Puro V, Ippolito G and The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-borne Infections in Dialysis. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. Nephron 1993; 64: 6369.
  • 3
    Albertoni F, Battilomo A, Di Nardo V, et al. Evaluation of a region-wide hepatitis B vaccination program in dialysis patients: experience in an Italian region. Nephron 1991; 58: 1803.
  • 4
    Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 5261.
  • 5
    Mioli VA, Balestra E, Bibiano L, et al. Epidemiology of viral hepatitis in dialysis centers: a national survey. Nephron 1992; 61: 178283.
  • 6
    Teles SA, Martins RMB, Gomes SA, et al. Hepatitis B virus transmission in Brazilian hemodialysis units: serological and molecular follow-up. J Med Virol 2002; 68: 419.
  • 7
    Vladutiu D, Cosa A, Neamtu A, et al. Infection with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepat 2000; 7: 3139.
  • 8
    Hutin YJF, Goldstein ST, Varma JK, et al. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999; 20: 7315.
  • 9
    Gahl GM, Hess G, Arnold W, Grams G. Hepatitis B virus markers in 97 long-term hemodialysis patients. Nephron 1979; 24: 5863.
  • 10
    Dueymes JM, Bodenes-Dueymes M, Mahe JL, Herman B. Detection of hepatitis B viral DNA by polymerase chain reaction in dialysis patients. Kidney Int 1993; 43: S1616.
  • 11
    Oesterreicher C, Hammer J, Koch U, et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995; 48: 196771.
  • 12
    Cabrerizo M, Bartolomè J, De Sequera P, Caramelo C, Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis and staff. J Am Soc Nephrol 1997; 8: 14437.
  • 13
    Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000; 32: 11623.
  • 14
    Minuk GY, Sun DF, Greenberg R, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 2004; 40: 10727.
  • 15
    Conjeevaram HS, Lok ASF. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001; 34: 2046.
  • 16
    Noborg U, Gusdal A, Horal P, Lindh M. Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 2000; 32: 24952.
  • 17
    Zignego AL, Fontana R, Puliti S, et al. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection. Arch Virol 1997; 142: 53544.
  • 18
    Lok ASF. Hepatitis B infection: pathogenesis and management. J Hepatol 2000; 32 (Suppl. 1): 8997.
  • 19
    Huo TI, Wu SC, Lee PC, et al. Seroclearance of hepatitis B surface antigen in chronic carriers does not necessary imply a good prognosis. Hepatology 1998; 28: 2316.
  • 20
    Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely ‘occult’? Hepatology 2001; 3: 194203.
  • 21
    Fabrizi F, Lunghi G, Alongi G, et al. Biological dynamics of hepatitis B virus load in dialysis population. Am J Kidney Dis 2003; 41: 127885.
  • 22
    Grob P, Jilg W, Bornhak H, et al. Serological pattern ‘anti-HBc alone’: report on a workshop. J Med Virol 2000; 62: 4505.
  • 23
    Albano A, Pianetti A, Biffi MR, et al. Prevalence of anti-HCV in subjects of various age groups. Eur J Epidemiol 1992; 8: 30911.
  • 24
    Hoofnagle JH, Seeff LB, Bales ZB, Zimmermann HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978; 298: 137983.
  • 25
    Thiers V, Kremsdorf D, Schellekens H, et al. Transmission of hepatitis B from hepatitis B seronegative subjects. Lancet 1988; i: 12736.
  • 26
    Chazouilleres O, Mamish D, Kim M, et al. ‘Occult’ hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343: 1426.
  • 27
    Dickson RC, Everhart JE, Lake JR, et al. Tramsmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997; 113: 166874.
  • 28
    Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998; 65: 4949.
  • 29
    Fabrizi F, Bunnapradist S, Martin P. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. J Nephrol 2002; 15: 60513.
  • 30
    Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg (−), HBcAb (+), HBIgM (−) organ donors. Transplantation 1995; 59: 2304.
  • 31
    Ihara H, Kato T, Ikeda H, Sekiguchi S. Evaluation of HI method as an anti-HBc screening test. Jpn J Transfus Med 1990; 36: 56.
  • 32
    Lai CL, Lau JYN, Yeoh EK, Chang WK, Lin HJ. Significance of isolated anti-HBc seropositivity by ELISA: implication and the role of radioimmunoassay. J Med Virol 1992; 36: 1803.
  • 33
    Abbott Diagnostics Division. Architect Anti-HBc Assay Package Insert. Abbott Park, IL 60064, USA, 2004.
  • 34
    Hofer M, Joller-Jemelka HI, Wicki AN, Grob PJ. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 1998; 17: 613.
  • 35
    Liaw YW, Shhen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991; 13: 62731.
  • 36
    Fattovich G, Tagger A, Brollo L, et al. virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991; 163: 4002.
  • 37
    Shih CM, et al. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993; 67: 582332.
  • 38
    Liaw YF, Chien RN, Chen TJ, Sheen IS, Chu CM. Concurrent hepatitis C virus and hepatitis Delta virus superinfection in patients with chronic hepatitis B virus infection. J Med Virol 1992; 37: 2947.
  • 39
    Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg negative patients: a study of a low-endemic area. Hepatology 1993; 17: 209.
  • 40
    Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14: 647.
  • 41
    Melegari M, Scaglioni PP, Wands JR. The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted. J Virol 1997; 71: 544954.
  • 42
    Bock CT, Tillmann HL, Mascheck HJ, Manns MP, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 1997; 113: 197682.
  • 43
    Uchida T, Shimojima S, Gotoh K, Shikata T, Mima S. Pathology of liver infection with ‘silent’ hepatitis B virus mutant. Liver 1994; 14: 2516.
  • 44
    Guh JY, Lai YH, Yang CY, et al. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995; 69: 45965.
  • 45
    Hung KY, Lee KC, Yen CJ, Wu KD, Tsai TJ, Chen WY. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 1997; 12: 1803.
  • 46
    Fabrizi F, Lunghi G, Colucci P, Finazzi S, Ponticelli C, Locatelli F. Reduced aminotransferase activity in patients with chronic renal failure not requiring dialysis: impact on the evaluation of viral hepatitis. Am J Kidney Dis 2001; 28: 100915.
  • 47
    Fabrizi F, Mangano S, Alongi G, et al. Influence of HBV viremia upon aminotransferase activity in dialysis population. Int J Artif Organs 2003; 26: 104855.